Much of EPAD’s progress is thanks to the collective effort of our team and our research participants; people like you who wish to support research into Alzheimer’s disease. We now have a driven and dedicated network across Europe and are bringing new research participants and trial delivery centers on board each month.
England / Wales
Spain / Greece
Thanks to this collaborative relationship between our research participants and professional team, we have just announced the launch of the EPAD platform for pharmaceutical and biotechnology companies. This means that we are now ready to start inviting research participants to join in clinical trials testing new medications. This is great news for our participants and the EPAD team and is a major milestone in the project!
We can’t do any of this without you, so if you are interested in becoming part of the EPAD family, please read on to find out more about participating in EPAD.